December 01, 2022 | by BBI Communications
‘Advancing genetic diagnoses of children through the analysis of blood, rather than tissue’
Read MoreJune 20, 2022 | by BBI Communications
Funding will enable mentoring of UW Medicine fellow and compare optical genome mapping with proximity ligation sequencing
Read MoreJune 23, 2022 | by BBI Communications
Funding ‘provides resources and intellectual freedom to make a lasting impact on the future of epigenetics research’
Read MoreApril 12, 2022 | by BBI Communications
‘Killing is not the hard part for the immune system. The hard part is precisely killing the right thing.’
Read MoreFebruary 28, 2022 | by BBI Communications
‘Hope to potentially deliver more information and more confidence in assessing the potential – or even likelihood – of children relapsing’
Read MoreJune 11, 2021 | by BBI Communications
Members of the Brotman Baty Institute for Precision Medicine (BBI) are using electronic health records to identify women with a risk of having a genetic predisposition to breast cancer.
Read MoreJune 01, 2021 | by BBI COMMUNICATIONS
“Although recent advances have led to a surge in the number of therapies available to treat Multiple Myeloma, it remains a challenge to identify which treatment a patient is most likely to respond to.” Dr. David Coffey, Fred Hutchinson Cancer Research Center
Read More